UK stocks reflected a quiet demeanor as investors awaited crucial data from the US and the UK. Notably, US CPI figures, as well as the UK's GDP and inflation metrics due to be released this week, are being keenly watched.
The FTSE 100, a key index for UK stocks, experienced a slight dip, lowering to 7,570, which followed a minor drop of 0.3 percent observed on the preceding Friday.
Even though crude oil prices retreated after a substantial six percent hike registered the previous week, both BP Plc and Royal Dutch Shell recorded a modicum of growth.
On the other hand, GSK saw a roughly one percent decline, even though it received a Fast Track designation from the US Food and Drug Administration (FDA) for its chronic hepatitis B drug, Bepirovirsen.
Tritax Big Box REIT encountered a considerable drop of over three percent. The real estate investment trust recently agreed to procure UK Commercial Property REIT Ltd, with the deal seeing each of the latter's shares exchanged for 0.444 new ordinary BBOX shares.
